BindingDB logo
myBDB logout

null

SMILES: C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(C)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO

InChI Key: InChIKey=WMFRVZTYALPKJC-OYRHEFFESA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 476698   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Dimer of Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM476698
PNG
(2-((2R,6S)-4-(3-((5-chloro-4-(6-methyl-1H-indole-3...)
Show SMILES C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(C)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO
Show InChI InChI=1S/C31H37ClN6O/c1-19-4-7-26-27(14-33-29(26)10-19)30-28(32)15-34-31(36-30)35-25-12-22(11-24(13-25)23-5-6-23)18-37-16-20(2)38(8-9-39)21(3)17-37/h4,7,10-15,20-21,23,33,39H,5-6,8-9,16-18H2,1-3H3,(H,34,35,36)/t20-,21+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a 7.20n/an/an/an/an/an/a


TBA



Citation and Details
More data for this
Ligand-Target Pair
Dimer of Receptor-type tyrosine-protein kinase FLT3


(Homo sapiens (Human))
BDBM476698
PNG
(2-((2R,6S)-4-(3-((5-chloro-4-(6-methyl-1H-indole-3...)
Show SMILES C[C@H]1CN(Cc2cc(Nc3ncc(Cl)c(n3)-c3c[nH]c4cc(C)ccc34)cc(c2)C2CC2)C[C@@H](C)N1CCO
Show InChI InChI=1S/C31H37ClN6O/c1-19-4-7-26-27(14-33-29(26)10-19)30-28(32)15-34-31(36-30)35-25-12-22(11-24(13-25)23-5-6-23)18-37-16-20(2)38(8-9-39)21(3)17-37/h4,7,10-15,20-21,23,33,39H,5-6,8-9,16-18H2,1-3H3,(H,34,35,36)/t20-,21+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 7.20n/an/an/an/an/an/a



HANMI PHARM. CO.. LTD.

US Patent


Assay Description
The inhibitory activity of some of the compounds described above against FLT3-ITD, FLT3 wild type (WT), VEGFR2 (KDR), and SYK kinase was measured.The...


US Patent US10870639 (2020)

More data for this
Ligand-Target Pair